Intrinsic Value of S&P & Nasdaq Contact Us

VectivBio Holding AG VECT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • CH • USD

SharesGrow Score
43/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$18.00
+6.7%

VectivBio Holding AG (VECT) reported total assets of $0.00 and total liabilities of $0.00 for quarter ending 2023-04-19, resulting in total equity of $0.00.

The company held $0.00 in cash and short-term investments. Total debt stood at $0.00.

Criteria supported by this page:

  • HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
  • MOAT (58/100) — Total assets $0.00 and equity $0.00 support the company's competitive scale

Overall SharesGrow Score: 43/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
43/100
SG Score
View full scorecard →
VALUE
60/100
Price-to-Earnings & upside
→ Valuation
FUTURE
88/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
58/100
Proven by this page
GROWTH
15/100
→ Income
INCOME
10/100
→ Income
VectivBio Holding AG Balance Sheet History
Metric Q1 FY2023 Q4 FY2022 Q2 FY2022 Q4 FY2021
Total Assets $0.00$252.6M$178.01M$136.53M
Total Liabilities $0.00$39.23M$36.19M$20.53M
Total Debt $0.00$10.46M$221K$292K
Cash & Investments $0.00$221.42M$142.14M$102.71M
Total Stockholders Equity $0.00$213.37M$141.83M$116M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message